Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73% Market Closed
Market Cap: 457.1m GBX
Have any thoughts about
Amryt Pharma Holdings Ltd?
Write Note

Net Margin
Amryt Pharma Holdings Ltd

-41.6%
Current
-88.9%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-41.6%
=
Net Income
-87.5m
/
Revenue
210.2m

Net Margin Across Competitors

Country UK
Market Cap 453.2m GBP
Net Margin
-42%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 771.1B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 368.9B USD
Net Margin
17%
Country US
Market Cap 249.4B USD
Net Margin
19%
Country CH
Market Cap 209.8B CHF
Net Margin
20%
Country CH
Market Cap 179.9B CHF
Net Margin
33%
Country UK
Market Cap 157.3B GBP
Net Margin
13%
Country IE
Market Cap 155B USD
Net Margin
-126%

Profitability Report

View the profitability report to see the full profitability analysis for Amryt Pharma Holdings Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-41.6%
=
Net Income
-87.5m
/
Revenue
210.2m
What is the Net Margin of Amryt Pharma Holdings Ltd?

Based on Amryt Pharma Holdings Ltd's most recent financial statements, the company has Net Margin of -41.6%.